Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 401
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01688323 | Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer | ||
| NCT00232505 | Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer | ||
| NCT07313306 | Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise | ||
| NCT07226271 | Consumer Perceptions of Alcoholic Beverages | ||
| NCT06252545 | Promoting CT Engagement for Pancreatic Cancer With App | ||
| NCT01789983 | Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy | ||
| NCT04504201 | Patient-centered Communication About Healthy Weight in Early Breast Cancer | ||
| NCT05926024 | Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment | ||
| NCT06902376 | XL092 and Cemiplimab in BRAF WT Thyroid Cancer | ||
| NCT04585893 | Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi | ||
| NCT05634785 | CD30 CAR for CD30+ NSGCT | ||
| NCT06096038 | Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC | ||
| NCT00744354 | Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT00280150 | Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | ||
| NCT04564989 | Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC | ||
| NCT00227032 | Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme | ||
| NCT05498220 | Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma | ||
| NCT00006061 | Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency | ||
| NCT03077243 | P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC | ||
| NCT05414097 | Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa | ||
| NCT00520000 | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors | ||
| NCT02700022 | A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas | ||
| NCT03602157 | Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL | ||
| NCT06519994 | Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya | ||
| NCT01208662 | Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | ||
| NCT00266097 | Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | ||
| NCT05362955 | 5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East Africa | ||
| NCT05887401 | Physical Activity and Healthy Eating Among Young Adult Cancer Survivors | ||
| NCT02167932 | The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer | ||
| NCT05743426 | Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies | ||
| NCT04999085 | Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma | ||
| NCT00088985 | Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer | ||
| NCT00003392 | High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | ||
| NCT07071909 | Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells | ||
| NCT06263582 | Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya | ||
| NCT03907657 | Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau | ||
| NCT01316146 | Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30) | ||
| NCT03488862 | Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients | ||
| NCT00233974 | Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery | ||
| NCT06306924 | UNC Metastatic Cancer Radiation Therapy Registry | ||
| NCT07065552 | Tirzepatide in Obesity-Driven Endometrial Cancer | ||
| NCT05311670 | Pre-Implementation Study of Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS) | ||
| NCT00073970 | Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy | ||
| NCT05722847 | Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer | ||
| NCT05377749 | The Families Addressing Cancer Together Intervention for Parents With Cancer | ||
| NCT02585973 | Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCC | ||
| NCT05742386 | Impact of Standing Orders Optimization | ||
| NCT04743674 | Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment | ||
| NCT00467727 | Visibility of Lesion Characteristics With Phase Contrast Mammography | ||
| NCT03977233 | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer |
